Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance

Diabetic Medicine

Volumn 26, Issue 9, 2009, Pages 847-854

  Perseghin, G ^a,b   Caumo, A ^a   Lattuada, G ^a   De Cobelli, F ^a,b   Ntali, G ^a   Esposito, A ^b   Belloni, E ^b   Canu, T ^b   Ragogna, F ^a   Scifo, P ^b   Del Maschio, A ^b,c   Luzi, L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Free fatty acids; Homeostasis model assessment; Intra hepatic fat; Magnetic resonance spectroscopy

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; PANCREAS ISLET BETA CELL; PROTON NUCLEAR MAGNETIC RESONANCE; SEX RATIO;

ADULT; B-LYMPHOCYTES; BLOOD GLUCOSE; C-PEPTIDE; FASTING; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 69249170017     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02785.x     Document Type: Article

References (35)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002 346 : 1221 1231.
2. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002 51 : 1889 1895. (Pubitemid 34564303)
3. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004 53 : 2855 2860.
4. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998 21 : 732 737.
5. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 : 1844 1850.
6. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002 87 : 3023 3028.
7. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002 23 : 201 229.
8. Perseghin G, Mazzaferro V, Piceni Sereni L, Regalia E, Benedini S, Bazzigaluppi E et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000 31 : 694 703.
9. Marchesini G, Pacini G, Bianchi G, Patrono D, Cobelli C. Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 1990 99 : 1715 1722.
10. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999 107 : 450 455.
11. Ferrannini E, Mari A. Beta-cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004 47 : 943 956.
12. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004 27 : 1487 1495.
13. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993 28 : 297 302. (Pubitemid 24079682)
14. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2004 288 : E462 E468.
15. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A et al. Habitual physical activity is associated with the intra-hepatic fat content in humans. Diabetes Care 2007 30 : 683 688.
16. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003 37 : 1202 1219.
17. Perseghin G, Lattuada G, De Cobelli F, Ntali G, Esposito A, Burska A et al. Serum resistin and intra-hepatic fat content in non-diabetic individuals. J Clin Endocrinol Metab 2006 91 : 5122 5125.
18. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non-obese individuals. J Clin Endocrinol Metab 2001 86 : 4776 4781.
19. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992 41 : 368 377.
20. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat by using magnetic resonance spectroscopy. Magn Reson Imaging 1994 12 : 487 495.
21. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G, on behalf of the EGIR. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997 100 : 1166 1173.
22. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 2007 92 : 3490 3497.
23. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycaemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005 54 : 603 608.
24. Holt HB, Wild SH, Wood PJ, Zhang J, Darekar AA, Dewbury K et al. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 2006 49 : 141 148.
25. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005 115 : 1343 1351.
26. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and re-esterification of plasma non-esterified fatty acids to plasma triglycefide synthesis during non-alcoholic fatty liver disease. Diabetes Metab 2003 29 : 478 485.
27. Utzschneider KM, Kahn SE. The role of insulin resistance in non-alcoholic fatty liver disease. J Clin Endocrinol Metab 2006 91 : 4753 4761.
28. 13C nuclear magnetic resonance study. J Clin Invest 1992 90 : 1323 1327.
29. Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003 77 : 43 50.
30. Iozzo P, Turpeinen AK, Takala T, Oikonen V, Bergman J, Gronroos T et al. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2004 89 : 3496 3502.
31. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 2007 104 : 12587 12594.
32. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006 116 : 2464 2472.
33. Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002 51 : 3025 3032.
34. Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance. Nat Clin Pract Endoc 2006 2 : 335 348.
35. Tushuizen ME, Bunck MC, Pouwels PJW, Bontemps S, Mari A, Diamant M. Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes. Eur J Endocrinol 2008 159 : 251 257.